You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (GenomeWeb) – Mesa Biotech announced today that it has received CE marking for its molecular diagnostic assay to detect respiratory syncytial virus (RSV). The point-of-care test will now be will marketed by select distributors in the EU.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.